Zhongke Green Valley (Shenzhen) Medical Technology Co., Ltd. was established in 2018, with the mission of "keeping integrity and innovation, escorting health", and is committed to becoming the backbone of human brain health. In 2022, Zhongke Green Valley was promoted to a national high-tech enterprise.

As the founder and leading brand of low-intensity transcranial focused ultrasound technology (tFUS) in China, Zhongke Green Valley has been firmly committed to the innovation and product development of a variety of physical non-invasive diagnosis and treatment technologies with original tFUS technology as the cornerstone of development. After years of technological innovation, Zhongke Green Valley has 62 patents, including 41 invention patents, 1 US patent and 4 PCT patents. Undertake and participate in the Ministry of Industry and Information Technology Shenzhen-Guangzhou high-end medical device advanced manufacturing cluster entity project 1, Shenzhen technology research major project 1. After arduous technical conquering and accumulation, Zhongke Green Valley has a variety of international cutting-edge technologies, including phased array transducer, focused acoustic beam excitation, intelligent electronic focus shift, magnetic resonance acoustic radiation force imaging, temperature imaging, multi-modal 3D rendering display, etc. The product line covers clinical neurodiagnosis, ultrasound neuroregulation, ultrasound imaging medicine, physical cognitive science research, AI brain-computer fusion and other sub-fields, related products have been certified by the ISO9001 quality management system, passed the authoritative biocompatibility test report, a variety of products into the clinical trial stage.

Zhongke Green Valley will continue to adhere to the business philosophy of "leading by science and technology, not only innovation", and regard leading the development and application of physical non-invasive diagnosis and treatment technology as the responsibility and glory given to us by the times.